Cambridge, United Kingdom

Katerine Van Rietschoten

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 5.6

ph-index = 7

Forward Citations = 90(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Katerine Van Rietschoten

Introduction: Katerine Van Rietschoten, an accomplished inventor based in Cambridge, GB, has made significant strides in the field of biochemistry, evidenced by her impressive portfolio of 12 patents. Her work focuses on the development of novel peptide ligands that play crucial roles in therapeutic applications, particularly through targeted delivery systems.

Latest Patents: Katerine's latest patents include groundbreaking innovations such as "Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)" and "Bicyclic peptide ligands specific for nectin-4." The first patent describes polypeptides that are covalently bound to molecular scaffolds, resulting in multimeric binding complexes that can specifically target and deliver therapeutic agents via TfR1. The second invention highlights high-affinity binders of Nectin-4, which can be utilized in drug conjugates aimed at treating disorders mediated by this receptor. Both patents emphasize the potential application of these peptide ligands in preventing, suppressing, or treating various diseases.

Career Highlights: Throughout her career, Katerine has contributed significantly to the fields of drug development and molecular biology. She has been associated with companies such as Bicycletx Limited and Bicyclerd Limited, where her innovative research has led to advancements in peptide technology and therapeutic applications.

Collaborations: Katerine has collaborated with notable individuals like Gemma Elizabeth Mudd and Paul John Beswick. These collaborations have enriched her research endeavors, allowing for the exchange of ideas and fostering a stimulating environment for innovation in their respective fields.

Conclusion: Katerine Van Rietschoten stands out as a leading inventor whose work on peptide ligands has the potential to revolutionize the delivery of therapeutic agents. With her multiple patents and collaborations, she continues to push the boundaries of biochemistry and medicine, making her an influential figure in the realm of innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…